Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

Name: Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)
Published: 2016
License: Public Domain

GlaxoSmithKline · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

arthritis efficacy pharmacodynamics pharmacokinetics rheumatoid rheumatoidarthritis safety

arthritis, rheumatoid, efficacy, safety, pharmacokinetics, pharmacodynamics, rheumatoid arthritis, autoimmune, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

Related documents